Ross Robert W.
- SEC CIK
- 0001733077
No open-market purchases or sales filed in the past year.
Current role at each company
- OBX Obsidian Therapeutics, Inc.Directoras of Aug 5, 2026
- XLO Xilio Therapeutics, Inc.Directoras of Jun 12, 2026
- SURF Surface Oncology, Inc.Chief Executive Officeras of Sep 8, 2023
Open-market trades in the past year
Open-market purchases (P) and sales (S) filed in the last 365 days, not counting derivative securities or duplicate filings. Values leave out price outliers.
- Bought
- –
- 0 filings
- Sold
- –
- 0 filings
- Net
- –
- Bought minus sold
- Companies
- 0
- With open-market trades
Trades
Every Form 4 that lists Ross Robert W. as a reporting owner, including filings made jointly with others, grouped by company. Each row adds up one type of transaction in one filing. Only open-market purchases (P) and sales (S) are shown by default.
SURF Surface Oncology, Inc.
Chief Executive Officer3 trades
| Filed (ET) | Trade date | Filing delay | Insider | Transaction | Shares | Avg price | Value | Holding change | Flags |
|---|---|---|---|---|---|---|---|---|---|
| Aug 11, 2023 (view filing) | Aug 1 | 10 daysLate | Ross Robert W.Chief Executive Officer | SSale | −16.7K | $0.94 | −$15.7K | −16.7%83.2K after | |
| Aug 5, 2022 (view filing) | Aug 3 | 2 days | Ross Robert W.Chief Executive Officer | SSale | −10.6K | $1.72 | −$18.2K | −9.6%99.9K after | |
| Jan 14, 2022 (view filing) | Jul 21, 2021 | 177 daysLate | Ross Robert W.Chief Executive Officer | SSale | −33.5K | $6.10 | −$204.3K | −38.1%54.5K after |